Literature DB >> 23264701

Cost-effective and Large-scale synthesis of 16:0 Lysophosphatidic Acid.

James E East1, Timothy L Macdonald.   

Abstract

Lysophosphatidic acid (LPA) is a bioactive compound that has gained attention due to its role in neoplastic diseases. Popularity of the compound has necessitated the use of large quantities of the phospholipid for in vivo and in vitro testing but methods for generating LPA require the use costly procedures, namely phosphoramidite coupling reagents. Additionally there has been no reported large-scale synthesis of LPA. In the present study we report the cost-effective and large-scale synthesis of 16:0 LPA.

Entities:  

Year:  2012        PMID: 23264701      PMCID: PMC3525677          DOI: 10.1080/00397911.2011.587080

Source DB:  PubMed          Journal:  Synth Commun        ISSN: 0039-7911            Impact factor:   2.007


  4 in total

1.  Efficient synthesis of phospholipids from glycidyl phosphates.

Authors:  Jan Lindberg; Johan Ekeroth; Peter Konradsson
Journal:  J Org Chem       Date:  2002-01-11       Impact factor: 4.354

2.  Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity.

Authors:  Lian Qian; Yong Xu; Yutaka Hasegawa; Junken Aoki; Gordon B Mills; Glenn D Prestwich
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

Review 3.  The emerging role of lysophosphatidic acid in cancer.

Authors:  Gordon B Mills; Wouter H Moolenaar
Journal:  Nat Rev Cancer       Date:  2003-08       Impact factor: 60.716

4.  Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.

Authors:  Lian Qian; Yong Xu; Hiroyuki Arai; Junken Aoki; Thomas M McIntyre; Glenn D Prestwich
Journal:  Org Lett       Date:  2003-11-27       Impact factor: 6.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.